What Researchers Did
The authors wrote a review of laboratory and clinical research on hyperbaric oxygen therapy (HBOT) in stroke.
What They Found
This review of experimental and clinical stroke research reports that HBOT has been studied in stroke since the 1960s, and that many basic and clinical studies have shown a beneficial effect on neurological outcome, but that evidence in human stroke is still not sufficient. The abstract names several possible mechanisms, including better cerebral oxygenation, protection of the blood-brain barrier, less inflammation and brain swelling, and less oxidative stress and cell death. It says there are too few randomized double-blind controlled clinical studies, and no uniform criteria for dose or session duration across different types of stroke. It also notes that HBOT combined with drugs and other treatments is being investigated. No sample sizes, pressures or session counts are given.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The authors say human stroke evidence is limited by too few randomized double-blind controlled trials, and that there is no agreed HBOT dose or session length, so the best protocol is still unknown.